Active ingredients
Pharmacological Group
Used in the treatment
- T37.1 Poisoning, antimycobacterial drugs
- Q90 Down's syndrome
- P10 Intracranial laceration and haemorrhage due to birth injury
- G80 Cerebral palsy
- G40 Epilepsy
- G21.3 Postencephalitic parkinsonism
- F79 Unspecified mental retardation
- F32 Depressive episode
- F29 Unspecified nonorganic psychosis
- F20 Schizophrenia
- B91 Sequelae of poliomyelitis
- A80 Acute poliomyelitis
- Y41.1 Adverse effects in therapeutic use, antimycobacterial drugs